Stocks in News today : 9 May 2025

has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL, single-dose prefilled syringes. Zydus’ generic Glatiramer Acetate Injection is an FDA-approved, AP-rated substitutable generics of Copaxone 20 mg/ml, 40 mg/ml and indicated for the treatment of relapsing forms of Multiple Sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Venus Pipes & Tubes has received LOI from one of India’s leading integrated power plant equipment manufacturers for Stainless Steel Seamless Boiler Tubes used in series of Supercritical and Subcritical Thermal Power Projects worth around Rs 190 crore (excluding GST). Formal order will be released shortly and is expected to be executed progressively during next 12-15 months. (IndiGo) has inked an agreement with Norwegian low-cost carrier Norse Atlantic Airways for damp leasing two more Boeing Dreamliner 787- aircraft bolstering its wide-body fleet. Norse Atlantic in November last year had announced signing a Letter of Intent for six such planes with a reputable airline. IndiGo is expanding its international footprint with plans to launch direct flights to Europe amid the rising international traffic from India. has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. Raltegravir Tablets are bioequivalent to Isentress HD Tablets, 600 mg of Merck Sharp & Dohme LLC. Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity. This product will be manufactured at Lupin’s Nagpur facility in India.